US 7229963
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
granted A61KA61K31/00A61K31/165
Quick answer
US patent 7229963 (Methods of using deacetylase inhibitors to promote cell differentiation and regeneration) held by United States of America as represented by the Secretary of the Department of of Health Services, National Institutes of Health expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Department of of Health Services, National Institutes of Health
- Grant date
- Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/00, A61K31/165, A61K31/19, A61P